Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients
NCT02218398 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2014-08-18
Summary
Investigators developed a test to assess the bronchodilator effects in mechanically ventilated chronic obstructive pulmonary disease patients by comparing the change of airway resistance. No matter whether patients respond to bronchodilator or not, they are randomized assigned to bronchodilator 3-4 times per day group and no bronchodilator group. Then investigators could objectively decide whether individual patients need or benefit from bronchodilator administration.
Conditions
Interventions
- DRUG
-
Albuterol
Sponsors & Collaborators
-
First Affiliated Hospital of Chongqing Medical University
collaborator OTHER -
Beijing Chao Yang Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-12-31
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation
NCT04509661 ·Status: UNKNOWN ·Phase: PHASE4
-
Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD
NCT03480997 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease
NCT06207331 ·Status: TERMINATED ·Phase: NA
-
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
NCT04042168 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure
NCT06571942 ·Status: RECRUITING ·Phase: PHASE4
-
Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00783250 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients.
NCT01120093 ·Status: COMPLETED ·Phase: PHASE2
-
A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator
NCT01794780 ·Status: COMPLETED ·Phase: PHASE4
-
Small Airways Evaluation and Treatment
NCT02526758 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways Disease
NCT00180843 ·Status: TERMINATED ·Phase: NA
-
Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD
NCT02937974 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT02275052 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01168310 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00856193 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation
NCT01712516 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma
NCT01837316 ·Status: COMPLETED ·Phase: PHASE1
-
RejuvenAir® System Trial for COPD With Chronic Bronchitis
NCT03893370 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
NCT01572792 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State
NCT02103374 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Umeclidinium Bromide/Vilanterol Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT01822899 ·Status: COMPLETED ·Phase: PHASE3
-
A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149
NCT01709903 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT02172352 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT03256695 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD
NCT02643082 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)
NCT00665600 ·Status: COMPLETED ·Phase: PHASE3